It’s thanks to unrelenting advocates like George Ackerman that we’ve made so much progress in understanding and treating Parkinson’s disease (PD). It was an honor to speak at @togetherforsharon.bsky.social about my research on dystonia, a debilitating and often overseen PD symptom.

Mind-blowing case of the day. This guy w/ Parkinson's has a left leg amputation. Later he develops phantom dystonia in the region of the missing limb? Eid, Rodrigo, and Norris teach us about the phenomenon through a case they published in the Movement Disorders Clinical Practice Journal.

New paper! Ethical considerations for the use of brain-computer interfaces for cognitive enhancement. Co-authored with Emma Gordon, and out now in @plos.bsky.social Biology. We should think for ourselves, while we still can journals.plos.org/plosbiology/...

The randomized trial results are in for the GLP-1 drug Exenatide for Parkinson's disease. Spoiler: NO symptomatic or disease modifying effect. Tom Foltynie, David Standaert and I interviewed in the NY Times by Gina Kolata. “This is a sobering moment."

🚨Interested in Dystonia?🚨 @braincircuits.bsky.social GPi DBS for dystonia is effective. More recently, STN DBS has been investigated, as an alternative. In what enfolded like a stunning thriller to me, Konstantin Butenko tells a tale of two networks… www.pnas.org/doi/10.1073/...

The brain’s action-mode is created by a dedicated action-mode network (AMN) rdcu.be/d5odm. In the brain’s mode continuum, AMN sits opposite DMN’s default-mode, as yin-yang. AMN might be key in pain, apathy, Parkinson’s. New @natrevneurosci.bsky.social w/ Marc Raichle & @gordonneuro.bsky.social 🧵 ⬇️

Updated DBS starter pack including numerous new folks – @raynorproject.bsky.social @parkinsondotorg.bsky.social welcome to @bsky.app! go.bsky.app/B9A9Cho